Insufficient scRNA-seq data for expression of CYP4F22 at single-cell level.
Insufficient scRNA-seq data for expression of CYP4F22 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 66% | 374.04 | 150 / 226 | 66% | 22.58 | 269 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.57 | 1 / 1 |
breast | 43% | 413.84 | 198 / 459 | 53% | 16.74 | 595 / 1118 |
bladder | 38% | 752.33 | 8 / 21 | 47% | 30.66 | 236 / 504 |
skin | 72% | 4456.97 | 1298 / 1809 | 10% | 3.40 | 47 / 472 |
esophagus | 35% | 708.27 | 512 / 1445 | 42% | 8.71 | 77 / 183 |
prostate | 47% | 955.10 | 116 / 245 | 21% | 1.73 | 104 / 502 |
tonsil | 0% | 0 | 0 / 0 | 33% | 3.33 | 15 / 45 |
uterus | 4% | 55.58 | 6 / 170 | 23% | 4.97 | 104 / 459 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.63 | 5 / 29 |
stomach | 13% | 69.03 | 48 / 359 | 1% | 0.03 | 3 / 286 |
adipose | 11% | 70.76 | 133 / 1204 | 0% | 0 | 0 / 0 |
lung | 0% | 0.40 | 1 / 578 | 11% | 1.11 | 123 / 1155 |
pancreas | 0% | 0 | 0 / 328 | 9% | 2.53 | 16 / 178 |
peripheral blood | 3% | 12.28 | 32 / 929 | 0% | 0 | 0 / 0 |
intestine | 0% | 0 | 0 / 966 | 3% | 0.65 | 14 / 527 |
kidney | 0% | 0 | 0 / 89 | 2% | 0.45 | 14 / 901 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.22 | 4 / 430 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.02 | 3 / 605 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.02 | 1 / 230 |
spleen | 0% | 1.00 | 1 / 241 | 0% | 0 | 0 / 0 |
brain | 0% | 0.09 | 1 / 2642 | 0% | 0.03 | 1 / 705 |
muscle | 0% | 1.55 | 1 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 2.70 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006690 | Biological process | icosanoid metabolic process |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0005515 | Molecular function | protein binding |
GO_0016705 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
Gene name | CYP4F22 |
Protein name | Cytochrome P450 4F22 Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) |
Synonyms | |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in epidermal ceramide biosynthesis. Hydroxylates the terminal carbon (omega-hydroxylation) of ultra-long-chain fatty acyls (C28-C36) prior to ceramide synthesis . Contributes to the synthesis of three classes of omega-hydroxy-ultra-long chain fatty acylceramides having sphingosine, 6-hydroxysphingosine and phytosphingosine bases, all major lipid components that underlie the permeability barrier of the stratum corneum . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) . . |
Accessions | A0A1B1SMS2 ENST00000269703.8 Q6NT55 ENST00000601005.2 |